JPH06271415A - Novel antifungal produced by lactobacillus and its compound - Google Patents
Novel antifungal produced by lactobacillus and its compoundInfo
- Publication number
- JPH06271415A JPH06271415A JP5285983A JP28598393A JPH06271415A JP H06271415 A JPH06271415 A JP H06271415A JP 5285983 A JP5285983 A JP 5285983A JP 28598393 A JP28598393 A JP 28598393A JP H06271415 A JPH06271415 A JP H06271415A
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial
- added
- coli
- hours
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000843 anti-fungal effect Effects 0.000 title abstract 3
- 229940121375 antifungal agent Drugs 0.000 title abstract 2
- 241000186660 Lactobacillus Species 0.000 title description 2
- 229940039696 lactobacillus Drugs 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract description 47
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 17
- 240000002605 Lactobacillus helveticus Species 0.000 claims abstract description 8
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims abstract description 8
- 229940054346 lactobacillus helveticus Drugs 0.000 claims abstract description 8
- 230000000844 anti-bacterial effect Effects 0.000 claims description 65
- 238000011160 research Methods 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 5
- 230000006866 deterioration Effects 0.000 abstract description 3
- 239000004599 antimicrobial Substances 0.000 abstract description 2
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 27
- 238000011156 evaluation Methods 0.000 description 26
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 22
- 241000588724 Escherichia coli Species 0.000 description 20
- 239000007788 liquid Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 18
- 238000012937 correction Methods 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 229920001817 Agar Polymers 0.000 description 13
- 239000008272 agar Substances 0.000 description 13
- 238000012258 culturing Methods 0.000 description 13
- 235000014655 lactic acid Nutrition 0.000 description 11
- 239000004310 lactic acid Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 8
- 108010039918 Polylysine Proteins 0.000 description 7
- 229920000656 polylysine Polymers 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 108010053775 Nisin Proteins 0.000 description 2
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000004309 nisin Substances 0.000 description 2
- 235000010297 nisin Nutrition 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000194035 Lactococcus lactis Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 108010076724 diplococcin Proteins 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 102220201851 rs143406017 Human genes 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Landscapes
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、乳酸菌産生の新規抗菌
物質に関し、更に詳しくは、乳酸菌株ラクトバチルス・
ヘルベティクスK−4(Lactobacillus helveticus K-
4、微工研菌寄12249 号)の産生する抗菌物質及びこれ
の配合物質に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel antibacterial substance produced by lactic acid bacteria, and more specifically, a lactic acid bacterium strain Lactobacillus
Helvetics K-4 (Lactobacillus helveticus K-
4. The present invention relates to antibacterial substances produced by Microtechnology Research Institute, Inc. 12249) and their compounding substances.
【0002】[0002]
【従来の技術】乳酸菌産生の抗菌物質として、乳酸など
の有機酸、過酸化水素、及びジアセチル等の低分子化合
物がすでに知られているが、その他に蛋白性の抗菌物質
の存在も知られている。例えば、ラクトコッカス・ラク
ティス(Lact. lactis)産生のナイシン(Nisin )
〔「ネイチャー(Nature)」、3913、551、19
44〕や、ラクトコッカス・クレモリス(Lact. cremor
is)産生のディプロコッキン(diplococcin )の報告
〔「バイオケミカル・ジャーナル(Biochem. J. )、3
8、178、1944〕などがある。しかしながら、ナ
イシン以外の物質の構造は明らかにされていないのが現
状である。2. Description of the Related Art Organic acids such as lactic acid, hydrogen peroxide, and low molecular weight compounds such as diacetyl are already known as antibacterial substances produced by lactic acid bacteria, but the existence of protein antibacterial substances is also known. There is. For example, Nisin produced by Lactococcus lactis
["Nature", 3913, 551, 19
44], and Lact. Cremoris (Lact. Cremor
is) production diplococcin report [Biochem. J., 3
8, 178, 1944]. However, at present, the structures of substances other than nisin have not been clarified.
【0003】また、ラクトバチルス・ヘルベティクス
は、ヨーグルトスターター、及びチーズスターターとし
て利用される有用な乳酸菌である。しかし、その発酵製
品に本発明で言う、ペプチド又はその複合体の様な高分
子の抗菌物質が産生されることはまだ知られていない。Lactobacillus helveticus is a useful lactic acid bacterium used as a yogurt starter and a cheese starter. However, it has not yet been known that the fermented product produces a macromolecular antibacterial substance such as a peptide or a complex thereof according to the present invention.
【0004】[0004]
【発明が解決しようとする課題】上述のように、乳酸菌
が産生する抗菌物質を得ることは、食品の変敗、腐敗防
止の抗菌手段として、重要な技術と成り得る。このよう
な見地から、本発明者らは乳酸菌の産生の蛋白性抗菌物
質について研究を重ねたところ、乳酸菌株ラクトバチル
ス・ヘルベティクスK−4中の抗菌物質を精製・同定、
及びその一次構造の解明に成功し本発明を完成するに至
ったものである。従って、本発明の課題は、新規乳酸菌
の産生する抗菌物質、該抗菌物質の配合物質、及び該抗
菌物質及びその配合物質を食品の変敗、腐敗防止の手段
として提供することにある。As described above, obtaining an antibacterial substance produced by lactic acid bacteria can be an important technique as an antibacterial means for preventing spoilage and spoilage of foods. From this point of view, the present inventors have conducted extensive research on proteinaceous antibacterial substances produced by lactic acid bacteria, and have purified and identified antibacterial substances in the lactic acid bacterium strain Lactobacillus helveticus K-4.
And its primary structure was successfully elucidated and the present invention was completed. Therefore, an object of the present invention is to provide an antibacterial substance produced by a novel lactic acid bacterium, a compounded substance of the antibacterial substance, and the antibacterial substance and the compounded substance thereof as means for preventing deterioration and spoilage of food.
【0005】[0005]
【課題を解決するための手段】すなわち、本発明は乳酸
菌株ラクトバチルス・ヘルベティクスK−4産生の抗菌
物質、H-Arg-Pro-Lys-His-Pro-Ile-Lys-His-Gln-OHの構
造を有するペプチド及びその複合体、及びこれらの抗菌
物質を配合してなる配合物質を内容とする。尚、複合体
とは、上記構造のペプチドを構造の一部に有し、且つ抗
菌機能を有するペプチドをいい、また配合物質とは、抗
菌ペプチドをデキストリン、デンプン等に増量を図る目
的で分散させたもの、あるいは抗菌ペプチドをポリリジ
ン、グリシン等の抗菌力を有する他の食品添加物ととも
に配合した物質をいう。[Means for Solving the Problems] That is, the present invention is an antibacterial substance produced by the lactic acid bacterium strain Lactobacillus helveticus K-4, H-Arg-Pro-Lys-His-Pro-Ile-Lys-His-Gln-OH. A peptide having the structure of and a complex thereof, and a compounded substance obtained by mixing these antibacterial substances are included. Incidentally, the complex means a peptide having a peptide having the above structure as a part of the structure and having an antibacterial function, and the compounding substance is dispersed for the purpose of increasing the amount of the antibacterial peptide in dextrin, starch or the like. Or a substance in which an antibacterial peptide is mixed with other food additives having antibacterial activity such as polylysine and glycine.
【0006】本発明の抗菌物質は以下に述べるような方
法により分離できるが、これに限定されない。The antibacterial substance of the present invention can be separated by the following method, but is not limited thereto.
【0007】[0007]
【実施例】以下、本発明を実施例に基づいて更に詳細に
説明するが、本発明はこれらに限定されるものではな
い。 実施例1 110℃で15分間滅菌した10%(W/W)還元脱脂
乳培地にラクトバチルス・ヘルベティクスK−4を1%
接種し24時間培養し、それを凝固させた。これを2回
繰り返したものを種菌とし、同培地に2%接種し72時
間培養して発酵乳を得た。次いで、日立高速遠心機で8
000rpm 、20 min. 遠心し、発酵乳から菌体を除き
培養上清を得た。以下、活性画分の決定は図1に示す抗
菌活性測定法(比濁法)で行い、精製は図2に示す抗菌
物質精製法で行った。各精製条件については表1〜3に
示した。The present invention will be described in more detail based on the following examples, but the invention is not intended to be limited thereto. Example 1 1% of Lactobacillus helveticus K-4 was added to 10% (W / W) reduced skim milk medium sterilized at 110 ° C. for 15 minutes.
Inoculated and cultured for 24 hours and allowed to solidify. This was repeated twice and used as an inoculum, and 2% was inoculated into the same medium and cultured for 72 hours to obtain fermented milk. Then, using a Hitachi high-speed centrifuge, 8
The cells were removed from the fermented milk by centrifugation at 000 rpm for 20 min to obtain a culture supernatant. Hereinafter, the active fraction was determined by the antibacterial activity measurement method (nephelometry) shown in FIG. 1, and the purification was carried out by the antibacterial substance purification method shown in FIG. The purification conditions are shown in Tables 1 to 3.
【0008】[0008]
【表1】 [Table 1]
【0009】[0009]
【表2】 [Table 2]
【0010】[0010]
【表3】 [Table 3]
【0011】即ち、培養上清50mlをセファデックス
(Sephadex)G−25を担体としたゲル濾過により分離
し、活性画分を得た。更に精製を進めるため、S−セフ
ァロース(Sepharose )FFを担体とした陽イオン交換
により分離を行ったところ、高い抗菌活性を示すピーク
を得た。この活性画分をSDS−PAGEにより分析し
たところ単一バンドが得られた。更に、この成分の脱
塩、精製のため逆相HPLCにかけたところ、単一ピー
ク、単一バンドと高い抗菌活性を確認した。更に、この
抗菌物質の一次構造を決定するために、ペプチドシーケ
ンサー(アプライド・バイオシス社)により分析した結
果、H-Arg-Pro-Lys-His-Pro-Ile-Lys-His-Gln-OHとして
一次構造が決定された。分子量は1248ダルトンであ
った。精製の過程における抗菌活性については表4に示
した。ここで言うunitとは、被検菌の生育による濁度の
上昇を1%抑制する抗菌活性を1 unitとした。That is, 50 ml of the culture supernatant was separated by gel filtration using Sephadex G-25 as a carrier to obtain an active fraction. For further purification, separation was carried out by cation exchange using S-Sepharose FF as a carrier, and a peak showing high antibacterial activity was obtained. When this active fraction was analyzed by SDS-PAGE, a single band was obtained. Further, when this component was subjected to reverse phase HPLC for desalting and purification, a single peak and a single band were confirmed to have high antibacterial activity. Furthermore, in order to determine the primary structure of this antibacterial substance, as a result of analysis by a peptide sequencer (Applied Biosys), the primary structure was H-Arg-Pro-Lys-His-Pro-Ile-Lys-His-Gln-OH. The structure was determined. The molecular weight was 1248 daltons. The antibacterial activity in the purification process is shown in Table 4. The term "unit" used herein means 1 unit of antibacterial activity that suppresses an increase in turbidity due to the growth of test bacteria by 1%.
【0012】[0012]
【表4】 [Table 4]
【0013】実施例2 うどんを表5に示す製法及び配合により調製し、これに
実施例1で得られた抗菌物質を配合し、10℃で保存テ
ストを実施した。pHはうどんと9倍量の蒸留水を均一
に混合した後測定した。一般生菌数については、標準寒
天培地に混釈して35℃で72時間培養し、コロニーの
数をカウントした。得られた結果を表6に示したが、精
製ペプチド1ppm の添加で充分高い抗菌活性を示した。Example 2 Udon was prepared according to the production method and the formulation shown in Table 5, and the antibacterial substance obtained in Example 1 was added to this, and a storage test was carried out at 10 ° C. The pH was measured after uniformly mixing udon and 9 times the amount of distilled water. Regarding the number of general viable cells, the number of colonies was counted by pouring into a standard agar medium and culturing at 35 ° C. for 72 hours. The results obtained are shown in Table 6, and the addition of 1 ppm of the purified peptide showed a sufficiently high antibacterial activity.
【0014】[0014]
【表5】 [Table 5]
【0015】[0015]
【表6】 食品の変敗、腐敗は、その種類または形態により異な
り、ペプチドの添加量については、上記種類や形態によ
り適宜決定される。[Table 6] Degradation and spoilage of food differ depending on the type or form thereof, and the amount of peptide added is appropriately determined depending on the type or form.
【0016】実施例3、比較例1、2 耐熱性を評価するにあたり、実施例1で得られた抗菌物
質を0.01M燐酸バッファー(pH=4.5)に10
0ppm になるように溶解し、評価サンプルとした。標準
液体培地にE. coli(IFO 1649) を103 コ/g植菌した
ものを比較例1とした。同様に、標準液体培地にE. col
i(IFO 1649) を103 コ/g植菌し、燐酸バッファーを
1%添加したものを比較例2とした。標準液体培地にE.
coli(IFO 1649) を103 コ/g植菌し、評価サンプル
を1%添加したものを実施例3(A)とした。標準液体
培地にE. coli(IFO 1649) を103 コ/g植菌し、12
1℃、15分加熱した評価サンプルを1%添加したもの
を実施例3(B)とした。各々を35℃、48時間培養
した後、標準寒天培地に希釈添加し35℃、72時間培
養後、菌数の測定をした。結果は表7に示すとおり、耐
熱性が認められた。Example 3, Comparative Examples 1 and 2 In evaluating the heat resistance, the antibacterial substance obtained in Example 1 was added to 0.01 M phosphate buffer (pH = 4.5) at 10%.
It melt | dissolved so that it might become 0 ppm, and it was set as the evaluation sample. Comparative Example 1 was prepared by inoculating 10 3 cells / g of E. coli (IFO 1649) in a standard liquid medium. Similarly, E. col was added to standard liquid medium.
Comparative Example 2 was prepared by inoculating 10 3 cells / g of i (IFO 1649) and adding 1% of phosphate buffer. E. standard liquid medium.
Example 3 (A) was prepared by inoculating 10 3 of coli (IFO 1649) / g and adding 1% of the evaluation sample. E. coli (IFO 1649) was inoculated into the standard liquid medium at a rate of 10 3 / g, and 12
Example 3 (B) was prepared by adding 1% of the evaluation sample heated at 1 ° C. for 15 minutes. Each was cultured at 35 ° C. for 48 hours, diluted and added to a standard agar medium, and cultured at 35 ° C. for 72 hours, and then the number of bacteria was measured. As shown in Table 7, heat resistance was confirmed.
【0017】[0017]
【表7】 [Table 7]
【0018】実施例4 抗菌力のpH特性を評価するにあたり、実施例1で得ら
れた抗菌物質を100ppm になるように水に溶解後、p
Hを3.5、4.5、6.5、8.5に調整し、評価サ
ンプルとした。標準液体培地にE. coli(IFO 1649) を1
03 コ/g植菌し、評価サンプルを各々1%添加し、各
々を35℃、48時間培養した後、標準寒天培地に希釈
添加し、35℃、72時間培養後菌数の測定をし、抗菌
性を評価した。結果は表8に示すとおり、広いpH領域
で抗菌性が認められた。Example 4 In evaluating the pH characteristics of antibacterial activity, the antibacterial substance obtained in Example 1 was dissolved in water to 100 ppm and then p
H was adjusted to 3.5, 4.5, 6.5, and 8.5 to obtain evaluation samples. Add E. coli (IFO 1649) to standard liquid medium
After inoculating 0 3 cells / g, adding 1% of each of the evaluation samples, culturing each at 35 ° C. for 48 hours, diluting and adding to standard agar medium, and culturing at 35 ° C. for 72 hours, the number of bacteria was measured. The antibacterial property was evaluated. As shown in Table 8, the results showed that the antibacterial property was observed in a wide pH range.
【0019】[0019]
【表8】 [Table 8]
【0020】実施例5、比較例3 実施例1で得られた抗菌物質にポリリジンを添加した配
合物質の特性を評価するにあたり、標準液体培地にE. c
oli(IFO 1649) を103 コ/g植菌し、ポリリジン(株
式会社チッソ社製)1%溶液を1%添加した試験区を実
施例5(A)とし、ポリリジン1%と抗菌物質0.5pp
m 添加の溶液を1%添加した試験区を実施例5(B)と
し、配合物質無添加のものを比較例3とした。各々を3
5℃、48時間培養した後、標準寒天培地に希釈添加し
35℃、72時間培養後、菌数を測定した。結果は表9
に示すとおり、抗菌力を有する食品添加物の抗菌性を高
めることが認められた。Example 5, Comparative Example 3 In evaluating the characteristics of the compounded substance obtained by adding polylysine to the antibacterial substance obtained in Example 1, E. c was added to a standard liquid medium.
oli (IFO 1649) was 10 3 U / g inoculated, polylysine (manufactured by Chisso Corporation) test group was added 1% 1% solution as in Example 5 (A), polylysine 1% and antimicrobials 0. 5pp
The test section in which 1% of the m-added solution was added was designated as Example 5 (B), and the one without the compounded substance was designated as Comparative Example 3. 3 each
After culturing at 5 ° C for 48 hours, it was diluted and added to a standard agar medium, and after culturing at 35 ° C for 72 hours, the number of bacteria was measured. The results are shown in Table 9.
As shown in, it was confirmed that the antibacterial properties of food additives having antibacterial activity were enhanced.
【0021】[0021]
【表9】 [Table 9]
【0022】実施例6 実施例1で分離・同定したペプチドと同じシーケンスを
有するペプチドを合成し、それらの相同性を比較した。
ペプチド合成は、ベガ社製ペプチドカプラー2200を
用いて同相合成法〔R.B.メリフィールド(Merrifie
ld)、「ジャーナル・オブ・ザ・アメリカン・ケミカル
・ソサイエティ(J.Am.Chem.Soc.)」Vol.85, p149 (19
63)〕により行った。 1.合成品の耐熱性評価 合成品の耐熱性を評価するにあたり、合成品を0.01
M燐酸バッファー(pH=4.5)に100ppm になる
ように溶解し、評価サンプルとした。標準液体培地にE.
coli(IFO 1649) を103 コ/g植菌したものを対照
区、標準液体培地にE. coli(IFO 1649) を103 コ/g
植菌し、評価サンプルを1%加えたものを添加区1、標
準液体培地にE. coli(IFO 1649) を103 コ/g植菌
し、121℃15分間加熱した評価サンプルを1%加え
たものを添加区2とした。各々を35℃、48時間培養
した後、標準寒天培地に希釈添加し35℃、72時間培
養後、菌数の測定をした。結果は表10に示すとおり、
耐熱性が認められた。Example 6 Peptides having the same sequence as the peptides separated and identified in Example 1 were synthesized and their homology was compared.
Peptide synthesis was carried out by the in-phase synthesis method [P. B. Merrifie
ld), "Journal of the American Chemical Society (J.Am.Chem.Soc.)" Vol.85, p149 (19
63)]. 1. Evaluation of heat resistance of synthetic products When evaluating the heat resistance of synthetic products, 0.01
It was dissolved in M phosphate buffer (pH = 4.5) at 100 ppm to obtain an evaluation sample. E. standard liquid medium.
coli (IFO 1649) control group and those 10 3 U / g inoculated, the standard liquid media E. coli (IFO 1649) 10 3 U / g
After inoculation and adding 1% of the evaluation sample, addition group 1, E. coli (IFO 1649) was inoculated into the standard liquid medium at 10 3 / g, and 1% of the evaluation sample heated at 121 ° C for 15 minutes was added. Addition group 2 was added. Each was cultured at 35 ° C. for 48 hours, diluted and added to a standard agar medium, and cultured at 35 ° C. for 72 hours, and then the number of bacteria was measured. The results are as shown in Table 10.
Heat resistance was recognized.
【0023】[0023]
【表10】 [Table 10]
【0024】2.合成品のpH依存性試験 合成品の抗菌力のpH特性を評価するにあたり、合成品
を100ppm になるように水に溶解後、pHを3.5、
4.5、6.5、8.5に調整し、評価サンプルとし
た。標準液体培地にE. coli(IFO 1649) を103 コ/g
植菌し、評価サンプルを各々1%添加し、各々を35
℃、48時間培養後、標準寒天培地に希釈添加し、35
℃で72時間培養し菌数の測定をし、抗菌性を評価し
た。結果は表11に示すように、広いpH域で抗菌性が
認められた。2. PH dependence test of synthetic products In evaluating the pH characteristics of the antibacterial activity of synthetic products, the synthetic products were dissolved in water to 100 ppm and the pH was adjusted to 3.5.
The samples were adjusted to 4.5, 6.5 and 8.5 and used as evaluation samples. E. coli (IFO 1649) was added to the standard liquid medium at 10 3 cells / g.
Inoculate, add 1% of each evaluation sample,
After culturing at ℃ for 48 hours, dilute and add to standard agar medium,
After culturing at 72 ° C for 72 hours, the number of bacteria was measured and the antibacterial property was evaluated. As a result, as shown in Table 11, antibacterial properties were observed in a wide pH range.
【0025】[0025]
【表11】 [Table 11]
【0026】3.合成品のグラム陰陽性菌に対する抗菌
効果 合成品のグラム陰陽性菌に対する抗菌効果を評価するに
あたり、合成品を100ppm になるように水に溶解後、
pHを4.5に調整し評価サンプルとした。標準液体培
地にE. coli(IFO 1649),S.aureus(IAM 1011)をそれぞれ
103 コ/g植菌し、評価サンプルを各々1%添加し、
35℃、48時間培養後、標準寒天培地に希釈添加し、
35℃で72時間培養し菌数の測定を行ない評価した。
結果は表12に示すように、両菌種に対して抗菌性が認
められた。3. Antibacterial Effect of Synthetic Products Against Gram-Yin Positive Bacteria To evaluate the antibacterial effect of Synthetic products against Gram-negative positive bacteria, after dissolving the synthetic products in water to 100 ppm,
The pH was adjusted to 4.5 to give an evaluation sample. E. coli (IFO 1649) and S. aureus (IAM 1011) were inoculated into the standard liquid medium at 10 3 cells / g each, and 1% of each evaluation sample was added.
After culturing at 35 ° C for 48 hours, dilute and add to standard agar medium,
After culturing at 35 ° C. for 72 hours, the number of bacteria was measured and evaluated.
As a result, as shown in Table 12, antibacterial properties were recognized against both bacterial species.
【0027】[0027]
【表12】 [Table 12]
【0028】以上のように、合成ペプチドは乳酸菌産生
のペプチドと同等の性質を有し、該ペプチドが前記一次
構造のシーケンスを有することが確認できた。As described above, it was confirmed that the synthetic peptide has the same properties as the peptide produced by lactic acid bacteria, and that the peptide has the sequence of the above primary structure.
【0029】[0029]
【発明の効果】本発明の抗菌物質は高い抗菌活性を示
し、食品の変敗、腐敗防止の抗菌手段として有効であ
る。The antibacterial substance of the present invention exhibits a high antibacterial activity and is effective as an antibacterial means for preventing deterioration and spoilage of food.
【図1】抗菌活性測定方法の説明図である。FIG. 1 is an explanatory diagram of a method for measuring antibacterial activity.
【図2】抗菌物質精製法の説明図である。FIG. 2 is an explanatory diagram of a method for purifying an antibacterial substance.
─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───
【手続補正書】[Procedure amendment]
【提出日】平成5年12月13日[Submission date] December 13, 1993
【手続補正1】[Procedure Amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0016[Correction target item name] 0016
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0016】実施例3、比較例1、2 耐熱性を評価するにあたり、実施例1で得られた抗菌物
質を0.01M燐酸バッファー(PH=4.5)に10
0ppmになるように溶解し、評価サンプルとした。標
準液体培地にE.coli(JCM 1649)を10
3コ/g植菌したものを比較例1とした。同様に、標準
液体培地にE.coli(JCM 1649)を103
コ/g植菌し、燐酸バッファーを1%添加したものを比
較例2とした。標準液体培地にE.coli(JCM
1649)を103コ/g植菌し、評価サンプルを1%
添加したものを実施例3(A)とした。標準液体培地に
E.coli(JCM 1649)を103コ/g植菌
し、121℃、15分加熱した評価サンプルを1%添加
したものを実施例3(B)とした。各々を35℃、48
時間培養した後、標準寒天培地に希釈添加し35℃、7
2時間培養後、菌数の測定をした。結果は表7に示すと
おり、耐熱性が認められた。Example 3, Comparative Examples 1 and 2 In evaluating the heat resistance, the antibacterial substance obtained in Example 1 was added to 0.01 M phosphate buffer ( PH = 4.5) at 10%.
It melt | dissolved so that it might become 0 ppm, and it was set as the evaluation sample. E. coli was added to standard liquid medium. coli (JCM 1649) 10
Comparative Example 1 was prepared by inoculating 3 cells / g. Similarly, standard liquid medium was added to E. coli. E. coli (JCM 1649) 10 3
Comparative Example 2 was prepared by inoculating co / g and adding 1% of phosphate buffer. E. coli was added to standard liquid medium. coli (JCM
1649) was inoculated with 10 3 cells / g and the evaluation sample was 1%.
The one added was designated as Example 3 (A). E. coli was added to standard liquid medium. Example 3 (B) was prepared by inoculating 10 3 cells / g of E. coli (JCM 1649) and adding 1% of the evaluation sample heated at 121 ° C. for 15 minutes. Each 35 ℃, 48
After culturing for a period of time, dilute and add to standard agar medium at 35 ° C for 7
After culturing for 2 hours, the number of bacteria was measured. As shown in Table 7, heat resistance was confirmed.
【手続補正2】[Procedure Amendment 2]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0018[Correction target item name] 0018
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0018】実施例4 抗菌力のpH特性を評価するにあたり、実施例1で得ら
れた抗菌物質を100ppmになるように水に溶解後、
pHを3.5、4.5、6.5、8.5に調整し、評価
サンプルとした。標準液体培地にE.coli(JCM
1649)を103コ/g植菌し、評価サンプルを各
々1%添加し、各々を35℃、48時間培養した後、標
準寒天培地に希釈添加し、35℃、72時間培養後菌数
の測定をし、抗菌性を評価した。結果は表8に示すとお
り、広いpH領域で抗菌性が認められた。Example 4 In evaluating the pH characteristics of antibacterial activity, the antibacterial substance obtained in Example 1 was dissolved in water to 100 ppm,
The pH was adjusted to 3.5, 4.5, 6.5, 8.5 and used as an evaluation sample. E. coli was added to standard liquid medium. coli (JCM
1649) was inoculated at a rate of 10 3 / g, 1% of the evaluation sample was added to each, and each was cultured at 35 ° C. for 48 hours, then diluted and added to a standard agar medium, and cultured at 35 ° C. for 72 hours to determine the number of bacteria. The measurement was performed to evaluate the antibacterial property. As shown in Table 8, the results showed that the antibacterial property was observed in a wide pH range.
【手続補正3】[Procedure 3]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0020[Correction target item name] 0020
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0020】実施例5、比較例3 実施例1で得られた抗菌物質にポリリジンを添加した配
合物質の特性を評価するにあたり、標準液体培地にE.
coli(JCM 1649)を103コ/g植菌し、
ポリリジン(株式会社チッソ社製)1%溶液を1%添加
した試験区を実施例5(A)とし、ポリリジン1%と抗
菌物質0.5ppm添加の溶液を1%添加した試験区を
実施例5(B)とし、配合物質無添加のものを比較例3
とした。各々を35℃、48時間培養した後、標準寒天
培地に希釈添加し35℃、72時間培養後、菌数を測定
した。結果は表9に示すとおり、抗菌力を有する食品添
加物の抗菌性を高めることが認められた。Example 5, Comparative Example 3 In evaluating the characteristics of the compounded substance obtained by adding polylysine to the antibacterial substance obtained in Example 1, E.
E. coli (JCM 1649) was inoculated with 10 3 cells / g,
A test section in which 1% of polylysine (manufactured by Chisso Corporation) was added as 1% was used as Example 5 (A), and a test section in which 1% of solution containing 1% of polylysine and 0.5 ppm of antibacterial substance was added was used as Example 5. Comparative Example 3 in which (B) is used and no compounded substance is added
And Each was cultured at 35 ° C. for 48 hours, diluted and added to a standard agar medium, cultured at 35 ° C. for 72 hours, and the number of bacteria was measured. The results, as shown in Table 9, were found to enhance the antibacterial properties of food additives having antibacterial activity.
【手続補正4】[Procedure amendment 4]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0022[Name of item to be corrected] 0022
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0022】実施例6 実施例1で分離・同定したペプチドと同じシーケンスを
有するペプチドを合成し、それらの相同性を比較した。
ペプチド合成は、ベガ社製ペプチドカプラー2200を
用いて同相合成法〔R.B.メリフィールド(Merr
ifield)、「ジャーナル・オブ・ザ・アメリカン
・ケミカル・ソサイエティ(J.Am.Chem.So
c.)」Vo1.85,p149(1963)〕により
行った。 1.合成品の耐熱性評価 合成品の耐熱性を評価するにあたり、合成品を0.01
M燐酸バッファー(pH=4.5)に100ppmにな
るように溶解し、評価サンプルとした。標準液体培地に
E.coli(JCM 1649)を103コ/g植菌
したものを対照区、標準液体培地にE.coli(JC
M 1649)を103コ/g植菌し、評価サンプルを
1%加えたものを添加区1、標準液体培地にE.col
i(JCM 1649)を103コ/g植菌し、121
℃15分間加熱した評価サンプルを1%加えたものを添
加区2とした。各々を35℃、48時間培養した後、標
準寒天培地に希釈添加し35℃、72時間培養後、菌数
の測定をした。結果は表10に示すとおり、耐熱性が認
められた。Example 6 Peptides having the same sequence as the peptides separated and identified in Example 1 were synthesized and their homology was compared.
Peptide synthesis was carried out by the in-phase synthesis method [P. B. Merrifield
ifiel), “Journal of the American Chemical Society (J. Am. Chem. So.
c. ) ”Vo 1.85, p149 (1963)]. 1. Evaluation of heat resistance of synthetic products When evaluating the heat resistance of synthetic products, 0.01
It was dissolved in M phosphate buffer (pH = 4.5) at 100 ppm to obtain an evaluation sample. E. coli was added to standard liquid medium. E. coli (JCM 1649) inoculated with 10 3 cells / g was used as a control, and E. coli (JC
M 1649) was inoculated at a rate of 10 3 / g, and 1% of the evaluation sample was added to the addition group 1, and the standard liquid medium was added to E. col
i (JCM 1649) was inoculated with 10 3 cells / g, 121
Addition section 2 was obtained by adding 1% of the evaluation sample heated at 15 ° C for 15 minutes. Each was cultured at 35 ° C. for 48 hours, diluted and added to a standard agar medium, and cultured at 35 ° C. for 72 hours, and then the number of bacteria was measured. As shown in Table 10, the heat resistance was confirmed.
【手続補正5】[Procedure Amendment 5]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0024[Name of item to be corrected] 0024
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0024】2.合成品のpH依存性試験 合成品の抗菌力のpH特性を評価するにあたり、合成品
を100ppmになるように水に溶解後、pHを3.
5、4.5、6.5、8.5に調整し、評価サンプルと
した。標準液体培地にE.coli(JCM 164
9)を103コ/g植菌し、評価サンプルを各々1%添
加し、各々を35℃、48時間培養後、標準寒天培地に
希釈添加し、35℃で72時間培養し菌数の測定をし、
抗菌性を評価した。結果は表11に示すように、広いp
H域で抗菌性が認められた。2. PH Dependence Test of Synthetic Product In evaluating the pH characteristics of the antibacterial activity of the synthetic product, the synthetic product was dissolved in water to 100 ppm and the pH was adjusted to 3.
The samples were adjusted to 5, 4.5, 6.5 and 8.5 and used as evaluation samples. E. coli was added to standard liquid medium. coli (JCM 164
9) was inoculated at a rate of 10 3 / g, 1% of each evaluation sample was added, and each was incubated at 35 ° C for 48 hours, diluted and added to a standard agar medium, and incubated at 35 ° C for 72 hours to measure the number of bacteria. And
The antibacterial property was evaluated. As shown in Table 11, the results show a wide p
Antibacterial properties were observed in the H range.
【手続補正6】[Procedure correction 6]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0026[Correction target item name] 0026
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0026】 3.合成品のグラム陰陽性菌に対する抗菌効果 合成品のグラム陰陽性菌に対する抗菌効果を評価するに
あたり、合成品を100ppmになるように水に溶解
後、pHを4.5に調整し評価サンプルとした。標準液
体培地にE.coli(JCM 1649),S.au
reus(IAM1011)をそれぞれ103コ/g植
菌し、評価サンプルを各々1%添加し、35℃、48時
間培養後、標準寒天培地に希釈添加し、35℃で72時
間培養し菌数の測定を行ない評価した。結果は表12に
示すように、両菌種に対して抗菌性が認められた。3. Antibacterial Effect of Synthetic Products Against Gram-Yin Positive Bacteria In evaluating the antibacterial effect of Synthetic products against Gram-negative positive bacteria, the synthetic product was dissolved in water to 100 ppm and the pH was adjusted to 4.5 to obtain an evaluation sample. . E. coli was added to standard liquid medium. coli (JCM 1649), S.I. au
Reus (IAM1011) was inoculated at 10 3 cells / g each, and 1% of the evaluation sample was added to each, and after culturing at 35 ° C. for 48 hours, diluted addition to standard agar medium was performed and culturing at 35 ° C. for 72 hours to determine the number of bacteria. The measurement was performed and evaluated. As a result, as shown in Table 12, antibacterial properties were recognized against both bacterial species.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 //(C12P 21/02 C12R 1:225) C07K 99:00 8318−4H ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 5 Identification code Office reference number FI technical display location // (C12P 21/02 C12R 1: 225) C07K 99:00 8318-4H
Claims (4)
(Lactobacillus helveticus K-4、微工研菌寄12249
号)の産生する抗菌物質。1. Lactobacillus helveticus K-4
(Lactobacillus helveticus K-4, Microtechnology Research Institute
No.) produced antibacterial substances.
e-Lys-His-Gln-OHの構造であるペプチド及びその複合体
である請求項1記載の抗菌物質。2. The antibacterial substance is H-Arg-Pro-Lys-His-Pro-Il.
The antibacterial substance according to claim 1, which is a peptide having a structure of e-Lys-His-Gln-OH and a complex thereof.
成して得られた抗菌物質。3. An antibacterial substance obtained by synthesizing a peptide containing the structure according to claim 2.
る配合物質。4. A compounded substance comprising the antibacterial substance according to any one of claims 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28598393A JP3476516B2 (en) | 1993-01-25 | 1993-10-19 | New antibacterial substance produced by lactic acid bacteria |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5-29814 | 1993-01-25 | ||
JP2981493 | 1993-01-25 | ||
JP28598393A JP3476516B2 (en) | 1993-01-25 | 1993-10-19 | New antibacterial substance produced by lactic acid bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06271415A true JPH06271415A (en) | 1994-09-27 |
JP3476516B2 JP3476516B2 (en) | 2003-12-10 |
Family
ID=26368061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP28598393A Expired - Lifetime JP3476516B2 (en) | 1993-01-25 | 1993-10-19 | New antibacterial substance produced by lactic acid bacteria |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3476516B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07115948A (en) * | 1993-10-27 | 1995-05-09 | Tamon Shuzo Kk | Preservative for food |
US6827952B2 (en) | 2001-03-30 | 2004-12-07 | Oriental Yeast Co., Ltd. | Lactic acid bacteria, fermented seasoning liquid containing the same, and a method for producing bread |
JP2023002622A (en) * | 2018-11-29 | 2023-01-10 | 雪印メグミルク株式会社 | Periodontal disease-preventing composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7666996B2 (en) | 2000-03-01 | 2010-02-23 | Peptera Pharmaceuticals Ltd | Casein derived peptides and uses thereof |
-
1993
- 1993-10-19 JP JP28598393A patent/JP3476516B2/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07115948A (en) * | 1993-10-27 | 1995-05-09 | Tamon Shuzo Kk | Preservative for food |
US6827952B2 (en) | 2001-03-30 | 2004-12-07 | Oriental Yeast Co., Ltd. | Lactic acid bacteria, fermented seasoning liquid containing the same, and a method for producing bread |
JP2023002622A (en) * | 2018-11-29 | 2023-01-10 | 雪印メグミルク株式会社 | Periodontal disease-preventing composition |
Also Published As
Publication number | Publication date |
---|---|
JP3476516B2 (en) | 2003-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Grosu-Tudor et al. | Characterization of some bacteriocins produced by lactic acid bacteria isolated from fermented foods | |
Roy et al. | Production of antifungal substance by Lactococcus lactis subsp. lactis CHD-28.3 | |
AU2007264660B2 (en) | Enhancer of proliferation of lactic acid bacterium, and agent for improvement in survivability of lactic acid bacterium | |
JPH04211360A (en) | New lactic acid bacterium, antimicrobial substance produced thereby, starter for fermenting milk containing the same bacterium and production of fermented milk using the same starter | |
US5635484A (en) | Propionibacteria peptide microcin | |
EP0521240B1 (en) | Novel bacteriocin from lactococcus lactis subspecies lactis | |
SEZER et al. | Investigation of bacteriocin production capability of lactic acid bacteria isolated from foods | |
KR100413335B1 (en) | Lactococcus lactis BH5(KCCM-10275) which is produced antimicrobial peptide | |
JP3476516B2 (en) | New antibacterial substance produced by lactic acid bacteria | |
EP0137869B1 (en) | Derived nisin producing microorganisms, method of production and use and products obtained thereby | |
RU2006104631A (en) | STABILIZED MATERIAL OF THE MILK BASE USED AS A SUBSTITUTE FOR BREAD CREAM | |
Dhanda et al. | Identification, purification, characterization and biopreservation potential of antimicrobial peptide of Pediococcus acidilactici NCDC 252 | |
Morales et al. | Hydrolysis of caseins and formation of hydrophilic and hydrophobic peptides by wild Lactococcus lactis strains isolated from raw ewes’ milk cheese | |
Veljovic et al. | Evaluation of antimicrobial and proteolytic activity of enterococci isolated from fermented products | |
McDougall et al. | Scanning electron microscopy of target cells and molecular weight determination of a bacteriocin produced by Lactococcus lactis D53 | |
D'angelis et al. | Purification, characterization and N‐terminal amino acid sequencing of sakacin 1, a bacteriocin produced by Lactobacillus sakei 1 | |
KR100273742B1 (en) | Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047) | |
Barefoot et al. | Lactacin B, a bacteriocin produced by Lactobacillus acidophilus | |
KR0155223B1 (en) | Culture medium for producing lactobacillus cells based on immersion water and molasses | |
EP1148064A1 (en) | Lactobacillus johnsonii bacteriocin, active against Helicobacter pylori | |
RU2492231C2 (en) | Method of bacteriocins isolation | |
Matsusaki et al. | Purification and identification of a peptide antibiotic produced by Lactococcus lactis IO-1 | |
KR20040079302A (en) | Novel bacteriocin isolated from human skin and the use as therapeutic agent of an acne | |
CN116003521B (en) | A Lactococcus lactis single-stranded DNA binding protein antimicrobial peptide Yt9z and its application | |
RU1819289C (en) | Kefir yeast tibetan used for kefir production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20030826 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070926 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080926 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080926 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090926 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100926 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110926 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110926 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120926 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120926 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130926 Year of fee payment: 10 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130926 Year of fee payment: 10 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |